Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению взрослых пациентов с хроническим запором

.

1. Wald A., Scarpignato C., Mueller-Lissner S., Kamm A., Hinkel U., Helfrich I., Schuijt C., Mandel G. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther 2008; 28(7):917-30.

2. Информация о заседании Экспертного совета по проблеме хронических запоров. Рос журн гастроэнтерол гепатол колопроктол 2011; 21(4):90-1.

3. Wald А., Sigurdsson L. Best Pract Res Clin Gastroenterol 2011; 25:19-27.

4. Yost J., Haan N., Levine A., et al. Comparing SF-36 scores across three groups of women with different health profiles. Qual Life Res 2005;14:1251-61.

5. Herz J., et al. Fam Pract 1996; 13(2):156-9.

6. Pare P., Ferrazzi S., Thompson G., Irvine J., Rance L. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001; 96(11):3130-7.

7. http://www.romecriteria.org/rome_III_gastro.

8. Chatoor D., Emmnauel A. Constipation and evacuation disorders. Best Pract Res Clin Gastroenterol 2009; 23(4):517-30.

9. Tariq H. Constipation in long-term care. Am Med Dir Assoc 2007; 8(4):209-18.

10. Bharucha E. Constipation. Best Pract Res Clin Gastroenterol 2007; 21(4):709-31.

11. World Gastroenterology Organisation Global Guidelines. Constipation: a global perspective. November 2010. http://www.worldgastroenterology.org/constipation. html

12. Fleming V., Wade E. A review of laxative therapies for treatment of chronic constipation in older adults. Am J Geriatr Pharmacother 2010; 8(6):514-50.

13. Lee-Robichaud H., Thomas K., Morgan J., Nelson L. Lactulose versus Polyethylene Glycol for Chronic Constipation(Review of the Cochrane Collaboration). The Cochrane Library 2011. Issue 1.

14. Tack J., Müller-Lissner S. Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol 2009; 7:502-8.

15. Petticrew M., Rodgers M., Booth A. Effectiveness of laxatives in adults. Qual Health Care 2001; 10:268-73.

16. Dupont C., Leluyer B., Maamri N., et al. Double-blind randomized еvaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr 2005; 41:625-33.

17. Migeon-Duballet I., Chabin M., Gautier A., et al. Longtеrm efficacy and cost-effectiveness of polyethylene glycol 3350 plus electrolytes in chronic constipation: a retrospective study in a disabled population. Curr Med Res Opin 2006; 22:1227-35.

18. Сorazziary E., Badialy D., Bazzocchi G., et al. Longterm efficacy, safety and tolerability of low doses of isosmotic polyethylene glycol electrolyte balanced solution [PMF-100] in the treatment of functional chronic constipation. Gut 2000; 46:522-6.

19. Loening-Baucke V., Pashankar D. A randomized, prospective study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence. Pediatrics 2006; 118:528-35.

20. Denis Ph., Lerebours E. Study of the long-term tolerance of Forlax in 16 patients treated for an average of 17 months for chronic constipation. Med Chir Dig 1996; 25(5).

21. Черемушкин В., Кучерявый А., и др. Ретроспективная оценка эффекта последействия при лечении хронического запора. Врач 2013; 3:58-62.

22. Bosshard W., Dreher R., Schnegg J., Bula C. The treatment of chronic constipation in elderly people: an update. Drugs Aging 2004; 21:911-30.

23. Ford A. An evidence-based systematic review on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104(suppl. 1):1-28.

24. Stanghellini V., Vandeplassche L., Kerstens R. Best response distribution of 12-week treatment with prucalopride(RESOLOR) in patients with chronic constipation: combined results of three randomised, doubleblind, placebo-controlled phase III trials. Gut 2011; 60(suppl. 1):159-60.

25. Camilleri M., et al. Clinical trial: the efficacy of openlabel prucalopride treatment in patients with chronic constipation follow-up of patients from the pivotal studies. Aliment Pharmacol Ther 2010; 32(9):1113-23.

26. Kerstens R., Vandeplassche L., Dubois D., et al. Gut 2010; 59(suppl. 3):360.

27. Tack J., et al. Poster presented at DDW May 17-22, 2008. San Diego, California.

28. Ramcumar P., Rao C. Functional anorectal disorders. In: Irvine J., Hunt H.(eds). Evidence-Based Gastroenterology. London: B.C.Decker, 2001:207-22.

29. Brandt J., Prather M., Quigley M., et al. Systemic review of the management of chronic constipation in North America. Am J Gastroenterol 2005; 100:5-22.

30. Terment A., Bastawrous L., Morin A., et al. Practice parameters for the evaluation and management of constipation. Dis Colon Rectum 2007; 50:2013-22.

31. Tack J., Müller-Lissner S., Stanghellini V., et al. Diagnosis and treatment of chronic constipation – a European perspective. Neurogastroenterol Motil 2011; 23:607-710.

32. Singh S., Rao S.S. Pharmacologic management of chronic constipation. Gastroenterol Clin North Am 2010; 39(3):509-27.